Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 2Withdrawn 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 55Prostatic Neoplasms 46Glioblastoma 28Brain Neoplasms 25Neoplasms 23Glioma 21Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 18Carcinoma, Hepatocellular 14Gliosarcoma 13Colorectal Neoplasms 12Uterine Cervical Neoplasms 11Neoplasm Metastasis 11Rectal Neoplasms 10Lymphoma, Non-Hodgkin 10Oligodendroglioma 9Melanoma 9Central Nervous System Neoplasms 9Astrocytoma 9Lymphoma 8Head and Neck Neoplasms 8Esophageal Neoplasms 8Colonic Neoplasms 8Ependymoma 7Squamous Cell Carcinoma of Head and Neck 6Pancreatic Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Carcinoma, Renal Cell 6Breast Neoplasms, Male 6Ovarian Neoplasms 5

Interventions

Filgrastim 11Temozolomide 9Peripheral Blood Stem Cell Transplantation 6Carboplatin 5Irinotecan 4sargramostim 3Oxaliplatin 3O(6)-benzylguanine 3Cyclophosphamide 3Vorinostat 2Vincristine 2Thiotepa 2Psychiatric Rehabilitation 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Etoposide 2Cisplatin 2Carmustine 2Busulfan 2veliparib 1trioctyl phosphine oxide 1romidepsin 1ribociclib 1phenylacetic acid 1palbociclib 1olaparib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Familial ependymoma × Magnetic Resonance Spectroscopy × Clear all
NCT00095940 2014-05-23

Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors

National Cancer Institute (NCI)

Phase 1/2 Completed
52 enrolled 17 charts
CNS

Familial ependymoma, Astrocytoma, Glioblastoma, Medulloblastoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡